Door To Device Time Goal For Endovascular Therapy

Of course. Here is a complete pillar blog post on the topic of door-to-device time goals for endovascular therapy.

The Unforgiving Clock: Why Door-to-Device Time is Everything in Endovascular Therapy

Imagine a patient collapsing in a hospital hallway. The clock starts the moment they arrive at the door. For the team rushing in with their tools, there’s one number that defines their entire mission: the door-to-device time. Every second that ticks by, millions of brain cells are dying. A stroke alert is called. It’s not just a metric on a chart; it’s the difference between walking out of the hospital and not. It’s the difference between a life saved and a life permanently altered.

This isn't a guideline you can debate. It's a physiological reality. Day to day, the brain is a time-sensitive organ, and for the kind of strokes treated with endovascular therapy, the clock is unforgiving. Understanding this single number is understanding the difference between recovery and disability.

What Is Door-to-Device Time, Exactly?

Let’s break down the term because it’s deceptively simple. "Door-to-device time" (often abbreviated as D2P, for Door-to-Puncture) is the elapsed time from the moment a patient arrives at the emergency department (the "door") to the moment the interventional team successfully opens a blocked artery with their device (the "device" — typically a stent retriever or thrombectomy aspiration catheter).

It’s crucial to distinguish this from other times in the stroke care chain. There’s "onset-to-door" time, which is how long it took the patient or their family to get to the hospital. There’s "door-to-needle" time, which is for patients receiving clot-busting IV medication. But door-to-device is specific to the mechanical, invasive procedure known as an endovascular thrombectomy.

This procedure is for a specific, severe type of stroke called a Large Vessel Occlusion (LVO). Consider this: think of it as a major plumbing issue in the brain's blood supply. IV tPA (the clot-busting drug) is like a gentle chemical solvent—it can work on smaller clogs but is often ineffective on a major blockage. Endovascular therapy is the high-pressure plumber’s snake. A neurosurgeon or interventional neuroradiologist threads a catheter from an artery in the groin or wrist all the way up to the blocked artery in the brain. They then deploy a stent to grab the clot or use suction to pull it out, physically restoring blood flow.

The door-to-device time is the measure of how efficiently the entire hospital system—from the triage nurse who recognizes the stroke symptoms to the interventional team in the angiography suite—can mobilize for this critical, life-saving procedure.

Why This Number Holds So Much Power

The "why" behind the urgency comes down to one concept: the ischemic penumbra. Here's the thing — this is the area of brain tissue surrounding the core of the stroke that is at risk of dying but hasn't yet. It's the tissue that can be saved. Which means this salvageable tissue doesn't have an infinite lifespan. It decays as blood flow is restricted.

Every minute that passes without restoring blood flow, more of this penumbra converts to irreversibly damaged core tissue. And the goal of endovascular therapy is to beat the clock, to open the vessel before the penumbra disappears. When the penumbra is gone, there’s no brain left to save, and the procedure becomes futile, no matter how technically perfect.

This directly translates to patient outcomes. In real terms, a shorter door-to-device time is overwhelmingly associated with:

Better functional independence: Patients are more likely to walk out of the hospital and live independently. * Reduced disability: Even if they survive, they are less likely to be left with severe, life-altering paralysis or cognitive deficits.
Lower mortality rates: The chances of surviving the stroke and its aftermath are significantly higher.

In essence, door-to-device time is a direct proxy for the quality and speed of the entire stroke care system. On top of that, a fast time means the system is working as a well-oiled machine. A slow time indicates bottlenecks, delays, and missed opportunities to save brain tissue.

The Evolving Goal: From 60 Minutes to 90 and Beyond

For years, the mantra was "time is brain," with aggressive goals of achieving a door-to-device time of under 60 minutes. So naturally, this was popularized by the "60-minute door-to-puncture benchmark. " While aspirational, research has shown that this is a challenging target for most hospitals to meet consistently.

Large, critical clinical trials like MR CLEAN, ESCAPE, and SWIFT PRIME established that endovascular therapy is highly effective up to 6 hours, and even longer in select cases with advanced imaging. This expanded the treatment window but also highlighted that the speed* within that window is still key.

This led to a more realistic and widely adopted goal: 90 minutes. But the American Heart Association/American Stroke Association (AHA/ASA) guidelines recommend a door-to-device time of 90 minutes or less for the majority of patients. This 90-minute target is considered a high-performance benchmark that is achievable with dedicated process improvement.

So, the goal isn't a single magic number but a tiered system:

Ideal: Under 60 minutes. So * Target: Under 90 minutes. * Acceptable: As fast as possible, with the understanding that even within the 6-24 hour window, faster is better.

The focus has shifted from a rigid stopwatch mentality to a "systems-based" approach. It’s not just about the neurointerventionalist being fast; it’s about the entire team—from EMS dispatch to radiology techs—working in seamless parallel, not in a sequential chain of command.

Common Mistakes and System Bottlenecks

Getting the door-to-device time down is rarely about one person working faster. It's about eliminating delays that happen at every step. Here are the most common culprits:

For more on this topic, read our article on how many liters is in a water bottle or check out what is 50 percent of 40.

The "Door-to-CT" Delay: This is the first major bottleneck. If a patient arrives with stroke symptoms, they need an immediate non-contrast CT scan to rule out a hemorrhage before any intervention. Delays in getting the patient to the scanner, waiting for the scan, or waiting for the radiologist to read it can eat up precious minutes.
The "CT-to-Decision" Lag: Once the CT scan is done, the images need to be interpreted. A delay in the neuroradiologist reading the scan or in communicating the findings to the stroke neurologist and the interventional team creates a critical lag.
The "Decision-to-Alert" Hesitation: This is the moment the team decides to proceed with a thrombectomy. Any hesitation—whether due to uncertainty about the diagnosis, waiting for a family consent conversation to conclude, or simply a slow chain of communication—adds significant time.
The "Alert-to-Team" Lag: Once the decision is made, the interventional team needs to be assembled and arrive at the suite. If team members are not on-site, if the angiography suite is occupied, or if there’s a delay in setting up, the clock keeps ticking.
Inefficient Workflow in the Suite: Once the patient is on the table, the procedure itself must be efficient. This includes rapid vascular access, swift catheter navigation, and effective clot retrieval

—all while maintaining procedural safety and efficacy. Even minor inefficiencies, like waiting for equipment to be prepared or delays in anesthesia administration, can meaningfully extend the total time.

Building a High-Performance Stroke System

Achieving consistent 90-minute door-to-device times requires a fundamental shift from individual heroics to system-wide optimization. This begins with establishing a dedicated stroke team that operates with 24/7 availability and clear, streamlined protocols.

Key strategies include:

Pre-notification and EMS Integration: When EMS recognizes stroke symptoms, they should immediately contact the hospital stroke team. This "911-to-hospital" notification allows the team to prepare en route, activating protocols and ensuring all necessary equipment and personnel are standing by.
Waste Reduction and Parallel Processing: Every step should be evaluated for redundancy or delay. Can the CT scan happen while the patient is still being examined? Can lab work be ordered before imaging results return? The goal is to eliminate sequential waits and run processes simultaneously where safe and appropriate.
Dedicated Stroke Pathways: Hospitals should have designated stroke codes and fast-track pathways that bypass routine administrative and clinical workflows. This includes having a dedicated MRI/CT suite, pre-stocked interventional carts, and immediate access to neurosurgery and interventional radiology teams.
Real-Time Monitoring and Feedback: Tracking door-to-device times in real-time and providing immediate feedback to teams helps identify bottlenecks as they occur. Regular debriefs after each case, especially longer ones, create opportunities for continuous improvement.

The Human Factor: Culture and Communication

Even the most optimized system can fail without the right culture. A high-performance stroke program requires psychological safety, where team members feel empowered to speak up about delays or potential issues without fear of blame. It demands clear, standardized communication protocols—using tools like SBAR (Situation, Background, Assessment, Recommendation) to ensure information flows quickly and accurately between departments.

Cross-training is also essential. Emergency department nurses, radiology technicians, and neurologists must all understand the urgency and their role in the chain. Regular simulation drills and tabletop exercises help teams practice responding to stroke codes, identifying communication gaps and workflow issues before they occur in real time.

Technology and Future Directions

While human factors are critical, technology continues to play an expanding role. Artificial intelligence is beginning to assist in rapid stroke diagnosis, potentially accelerating the CT-to-decision phase. Advanced triage tools like the Canadian Stroke Pre-hospital Risk Screen (CSPRS) help EMS prioritize patients. Telemedicine bridges geographic gaps, allowing stroke neurologists to consult on cases at remote hospitals and guide transfers to thrombectomy-capable centers.

Future innovations may include portable CT scanners for ambulatory use and AI-driven predictive models that can forecast which patients are most likely to benefit from intervention, further streamlining decision-making.

Conclusion

The 90-minute door-to-device target represents more than a performance metric—it’s a commitment to systems thinking in stroke care. By understanding and eliminating the common bottlenecks that plague the stroke care continuum, hospitals can transform a complex, multi-step process into a fluid, efficient workflow. It’s about creating a culture where speed and safety coexist, where every team member understands their role in a collective mission, and where continuous improvement is built into the DNA of patient care. In the race against time that defines stroke treatment, it’s not the fastest individual that wins—it’s the most coordinated team.